Avac Event

HIV Vaccine Awareness Day Webinar Series

This year marks the 25th anniversary of HIV Vaccine Awareness Day. Nothing about HIV vaccine research has ever been easy, and this past year has shown us how difficult this research is, and how essential it continues to be.

Join us for a webinar series this month to mark important milestones in HIV vaccine development and discuss the path forward. The series is chaired by Bill Snow and Stacey Hannah and offers expert perspective on three angles that are critical to vaccine development: Platforms, Processes and Prospects.

Platforms & Pipelines
Wednesday May 18, 2022
The miracle of mRNA: What’s possible beyond SARS-CoV-2—understanding mRNA, its history and potential challenges for HIV vaccines. With Bart Haynes (Duke), Nina Russel (Bill & Melinda Gates Foundation) and Ntando Yola (DTHF).
Recording and Slides: YouTube / Nina Russell’s Slides / Bart Haynes’ Slides

Processes
Tuesday May 24, 2022
The changed landscape of clinical research: the potential for experimental medicine vaccine trials in the current research environment. With Gail Broder (HVTN), Pontiano Kaleebu (MRC-UK) and Robin Shattock (Imperial College).
Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides

Prospects
Tuesday May 31, 2022 @ 10.00am EDT
What have we learned, why it matters and what it means? Understanding recent results in HIV vaccine research and implications for the future. Unpacking results from Uhambo and Imbokodo trials and understanding the implications for the current pipeline of products. With Galit Alter (Harvard), William Kilembe (ZEHRP), Ethel Makila (IAVI) and Dale Hu (NIH).
Recording: YouTube

Avac Event

HVAD 2022 Webinar: Processes

On Tuesday, May 24, 2022, AVAC and partners held Processes, the second webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the changed landscape of clinical research and the potential for experimental medicine vaccine trials in the current research environment.

Moderators:
Panelists:

Recording and Slides: YouTube / Robin Shattock’s Slides / Gail Broder’s Slides / Pontiano Kaleebu’s Slides

Avac Event

HVAD 2022 Webinar: Prospects

On Tuesday, May 31, AVAC and partners held Prospects, the third webinar in our HVAD 2022 webinar series. The moderators and panelists discussed the what we have learned, why it matters and what it means. They looked at recent results in HIV vaccine research and implications for the future, unpacked results from Uhambo and Imbokodo trials and talked about the implications for the current pipeline of products.

Moderators:
Panelists:

Watch the recording here.

Avac Event

Risky Women: Disrupting simple notions of women’s HIV risk

The final webinar of the Fall series discussed what is known from social and behavioral science and community experience about the definitions and perceptions of HIV risk among women that are relevant to their potential PrEP use.

Avac Event

PrEP-ception: Sero-discordant couples using PrEP to reduce HIV transmission risk during pregnancy

The second in a series of webinars by the US Women and PrEP Working Group discussed the possibilities and challenges associated with serodiscordant couples using PrEP to help them achieve pregnancy safely.

Avac Event

HIV Prevention Europe Webinars: Rectal microbicides

The seventh webinar in our series addressing a range of topics in HIV prevention research, hosted jointly by NAM and AVAC, will focus on rectal microbicides. The presentation was followed by a Q&A session.

Avac Event

How to Communicate about Sexual Health and STIs: Sex positivity vs. risk-based language

Thursday, April 20 at 9:30 AM – 11:00 AM ET

Join The Choice Agenda for a conversation focused on sex positivity and risk-based language when discussing sexual health and STIs.

Speakers include Dr. Keosha T. Bond, CUNY School of Medicine, Dr. Joseph Cherabie, Washington University St. Louis, Mark Kaigwa, Nendo, and moderated Alison Footman, AVAC

Webinar co-sponsored by the American Sexual Health Association.

Click here to convert the time to your location.

Register here.

This webinar is a part of The Choice Agenda.

Avac Event

Global PPPR Equity: Why do we need agreements on IP and tech transfers?

April 6, 2023, 9:00AM Washington/2:00PM London/4:00PM Nairobi

Over the past two decades, HIV advocates have engaged in hard battles for equitable access to HIV/AIDS drugs and prevention options and have had some big wins. The process of these negotiations has led to strong relationships that have enshrined certain equity provisions as standard in clinical trials and manufacturing of HIV drugs. Through these battles, we’ve learned clear lessons on the necessity for such agreements and what’s required to secure them.

Throughout global PPPR agreements in 2023, governments and advocates in the Global South are asking for provisions on equity in the form of temporary IP waivers, mandatory tech transfer, and mandatory licensing for pandemic tools.

This panel will discuss lessons from the HIV epidemic and explore why governments of the Global South and advocates think we still need to address ‘the IP question’.

Featured Speakers: Fifa Rahman, Brook Baker, Fitsum Lakew, and moderated by Samantha Rick, AVAC

Register here.

Avac Event

PrEP That Booty: The latest on rectal microbicide research for the back door

Thursday, June 29 at 9:00 AM–10:30AM ET

Most of what we hear about regarding the HIV prevention pipeline is about long-acting, longer-acting, and even longer-acting products that deliver drug throughout the body and require a trained clinician to deliver. However, these attributes are not desirable to many folks, and communities want a range of choices. Researchers and advocates for years have been working on HIV prevention products specifically for the back door (rectum) to provide protection during anal intercourse. These products are user-controlled, non-systemic (the drug stays in the booty and only the booty), and are short-acting, so you don’t have to commit to having a prevention drug in your body for a year or longer. Join us for a dynamic discussion regarding the latest research on Booty PrEP – aka rectal microbicides – with our multi-talented panel.

Speakers include: Jonathan Baker, PA, Laser Surgery Care, Dr. Craig Hendrix, Johns Hopkins, Juan Michael Porter II, The Body, and Dr. Sharon Riddler, University of Pittsburgh

Register here.

Avac Event

PrEP (In)equity: Documenting, measuring, and flipping the script towards justice

Tuesday, May 9 at 9:00 AM–10:30AM ET

Disparities in PrEP awareness, access, and uptake are stark in the United States, and play out along lines of race, gender, age, and geography. While we see increases in PrEP uptake overall, these metrics tend to mask the fact that the people who most need PrEP are not to be found in those numbers. As we see new modes of PrEP delivery become available, we are concerned these “shiny new things” will be yet another way to measure disparities and not actually help those who most need it. We must focus on these inequities with laser-like intensity, allocate resources using an equity model, and strive harder for PrEP justice.

Speakers include: Leisha-McKinley Beach, National HIV/AIDS Consultant, Michael Chancley, PrEP4All, and Dr. Patrick Sullivan, Emory

Register here.